Beryl Drugs standalone net profit rises 440.00% in the September 2017 quarter

Sales rise 7.33% to Rs 3.22 crore

Net profit of Beryl Drugs rose 440.00% to Rs 0.54 crore in the quarter ended September 2017 as against Rs 0.10 crore during the previous quarter ended September 2016. Sales rose 7.33% to Rs 3.22 crore in the quarter ended September 2017 as against Rs 3.00 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales3.223.00 7 OPM %7.459.00 -PBDT0.210.22 -5 PBT0.110.12 -8 NP0.540.10 440

Powered by Capital Market - Live News